Rare diseases
Investigational molecules
Locations
Back to Greece680 clinical trials in Efkarpia, Greece. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GreeceΚλινικεσΔοκιμεσ.gr(opens in a new tab)Study on Emapalumab for Patients with Sepsis Linked to Interferon-Gamma
GreeceStudy on the Effectiveness and Safety of Frexalimab and Teriflunomide in Adults with Relapsing Multiple Sclerosis
GreeceStudy on the Effects of Cenerimod for Adults with Moderate to Severe Systemic Lupus Erythematosus
GreeceStudy of Retifanlimab, INCAGN02385, and INCAGN02390 for First-Line Treatment in Patients with PD-L1 Positive Recurrent/Metastatic Head and Neck Cancer
GreeceStudy on Long-term Safety and Effects of Efgartigimod PH20 SC for Adults with Bullous Pemphigoid
GreeceStudy on the Safety and Effectiveness of Volrustomig with a Drug Combination for Patients with Solid Tumors
GreeceStudy on Datopotamab Deruxtecan and Osimertinib for Patients with Advanced Non-Small Cell Lung Cancer After Osimertinib Treatment
GreeceStudy of Tiragolumab and Atezolizumab for Patients with Advanced Non-Small Cell Lung Cancer
GreeceThe busiest research cities in the country
What the registry says about research in the country
Extensive trials focusing on hidradenitis suppurativa and atopic dermatitis, evaluating novel therapeutic approaches and treatment combinations to improve patient outcomes.
Multiple studies testing new biological therapies and their long-term safety profiles.
Research centered on lupus erythematosus and Sjögren's Disease, investigating targeted therapies to manage disease progression and symptoms.
Studies aim to evaluate new therapeutic agents for better disease control.
Innovative trials examining treatments for Type 2 Diabetes and obesity, with focus on cardiovascular outcomes and weight management.
Research comparing new therapeutic options against established treatments.
Advanced research in metastatic breast cancer and colorectal cancer, evaluating targeted therapies and combination treatments.
Focus on improving progression-free survival in advanced disease stages.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
